These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2823391)

  • 21. Inhibition of Ca2+ channel current by mu- and kappa-opioid receptors coexpressed in Xenopus oocytes: desensitization dependence on Ca2+ channel alpha 1 subunits.
    Kaneko S; Yada N; Fukuda K; Kikuwaka M; Akaike A; Satoh M
    Br J Pharmacol; 1997 Jun; 121(4):806-12. PubMed ID: 9208152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly).
    Bhargava HN; Ramarao P
    Prog Clin Biol Res; 1990; 328():493-6. PubMed ID: 2154810
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the highly selective kappa opioid, U-50, 488, on renal function in the anesthetized dog.
    Slizgi GR; Taylor CJ; Ludens JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):641-5. PubMed ID: 6088759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis and analgesic activity of 3,4-dichloro-N-methyl-N-[trans-2-(1-delta 3-pyrrolinyl)-cyclohexyl]-benzenacetamide hydrochloride].
    Ma SC; Lu SN; Li KZ; Wang CQ
    Yao Xue Xue Bao; 1986 Nov; 21(11):861-3. PubMed ID: 3035865
    [No Abstract]   [Full Text] [Related]  

  • 25. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
    Kasparov SA
    Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
    Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
    Li FC; Sun XJ; Hu WH; Jen MF
    Yao Xue Xue Bao; 1994; 29(12):881-6. PubMed ID: 7709739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats.
    Carter DA; Lightman SL
    J Physiol; 1985 Oct; 367():363-75. PubMed ID: 2997441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperalgesic effect of the selective kappa opioid agonist, U-50488H in mice.
    Ramabadran K
    Jpn J Pharmacol; 1983 Dec; 33(6):1289-92. PubMed ID: 6321836
    [No Abstract]   [Full Text] [Related]  

  • 32. FMRFamide suppresses kappa opiate induced feeding in the mouse.
    Kavaliers M; Hirst M
    Peptides; 1985; 6(5):847-9. PubMed ID: 3001666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nor-binaltorphimine on the behavior of mice and rats receiving multiple injections of U-50,488.
    Cowan A; Murray CW
    Prog Clin Biol Res; 1990; 328():303-6. PubMed ID: 2154786
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.
    Tavani A; Gambino MC; Petrillo P
    J Pharm Pharmacol; 1984 May; 36(5):343-4. PubMed ID: 6145777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that the kappa agonist U50488H has non-opioid actions.
    Hayes AG; Birch PP; Cavicchini E
    J Pharm Pharmacol; 1988 Oct; 40(10):718-20. PubMed ID: 2907540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The amygdala mediates the impairing effect of the selective kappa-opioid receptor agonist U-50,488 on memory in CD1 mice.
    Castellano C; Libri V; Ammassari-Teule M
    Behav Brain Res; 1988 Oct; 30(3):259-63. PubMed ID: 2846004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid receptor independent inhibition of Ca2+ and K+ currents in NG108-15 cells by the kappa opioid receptor agonist U50488H.
    Carpenter E; Gent JP; Peers C
    Neuroreport; 1996 Jul; 7(11):1809-12. PubMed ID: 8905670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.
    Hall ED; Wolf DL; Althaus JS; Von Voigtlander PF
    Brain Res; 1987 Dec; 435(1-2):174-80. PubMed ID: 2827851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ethanol in an open field apparatus: modification by U50488H and WIN 44441-3.
    Pohorecky LA; Patel V; Roberts P
    Physiol Behav; 1989 Feb; 45(2):273-87. PubMed ID: 2547220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.